Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma

被引:0
作者
Hanna Ronkainen
Pasi Hirvikoski
Saila Kauppila
Katri S Vuopala
Timo K Paavonen
Katri S Selander
Markku H Vaarala
机构
[1] Oulu University Hospital,Department of Surgery
[2] Lansi Pohja Central Hospital,Department of Pathology
[3] University of Oulu,Department of Pathology
[4] Lapland Central Hospital,Department of Pathology
[5] University of Tampere and Tampere University Hospital,Department of Pathology
[6] School of Medicine,Department of Medicine, Division of Hematology
[7] University of Alabama at Birmingham,Oncology
[8] University of Oulu,Department of Anatomy and Cell Biology
来源
Journal of Experimental & Clinical Cancer Research | / 30卷
关键词
renal cell carcinoma; toll-like receptor 9; tumour necrosis; prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 205 条
[1]  
Pantuck AJ(2001)The changing natural history of renal cell carcinoma J Urol 166 1611-1623
[2]  
Zisman A(2001)Prognostic factors and molecular markers for renal cell carcinoma Expert Rev Anticancer Ther 1 565-575
[3]  
Belldegrun AS(2003)Recognition of pathogen-associated molecular patterns by TLR family Immunol Lett 85 85-95
[4]  
Bui MH(2004)The immunobiology of the TLR9 subfamily Trends Immunol 25 381-386
[5]  
Zisman A(2004)Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors J Biol Chem 279 19008-19017
[6]  
Pantuck AJ(2004)TLR9 is localized in the endoplasmic reticulum prior to stimulation J Immunol 173 1179-1183
[7]  
Han KR(2011)A novel Toll-like receptor that recognizes vesicular stomatitis virus J Biol Chem 286 4517-4524
[8]  
Wieder J(2005)Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation J Immunol 175 8242-8252
[9]  
Belldegrun AS(2005)Human lung cancer cells express functionally active Toll-like receptor 9 Respir Res 6 1-447
[10]  
Akira S(2006)Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity Mol Cancer Res 4 437-781